Emerging significance of NLRs in inflammatory bowel disease.
about
Mitochondrial dysfunction in inflammatory bowel diseaseModeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori InfectionCaspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesisThe NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesisDiminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells.NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.The Goldilocks Conundrum: NLR Inflammasome Modulation of Gastrointestinal Inflammation during Inflammatory Bowel DiseaseThe pathogenic role of the inflammasome in neurodegenerative diseases.Microbiota as a mediator of cancer progression and therapy.Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease.Quelling Inflammation with Ketosis and Steric Chemistry.Exome sequencing and genotyping identify a rare variant in NLRP7 gene associated with ulcerative colitis.The Intricate Link among Gut "Immunological Niche," Microbiota, and Xenobiotics in Intestinal Pathology.Characterization of Inflammasome Components in Pig Intestine and Analysis of the Influence of Probiotic Enterococcus Faecium during an Escherichia Coli Challenge.The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans.NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.Nucleotide-Binding Domain Leucine-Rich Repeat Containing Proteins and Intestinal Microbiota: Pivotal Players in Colitis and Colitis-Associated Cancer Development.
P2860
Q26781311-DFC31E66-875E-4A15-8813-59B21A537D8BQ34494038-F23FAB35-6CA7-4576-9503-48AF061F4C25Q34980689-74E41976-DB24-4947-A54C-CC9A3518C09AQ35205390-EBC4977D-9B5E-4F1D-AE95-6E9FEF99DB2DQ35994949-E1917019-9637-482B-A08A-F8B4976D1F1CQ37362848-4695B93B-303C-410A-9385-19303DAEDE2FQ37719963-25D8D509-B4F9-4864-B0D9-0FA9748B9351Q38539519-507BE879-0686-49E0-89A8-4AD1A5B17EAFQ38935534-9371EDE5-38DE-4F66-A0BD-5B46C0230195Q39351075-737D3187-9D2C-4797-80A2-7D8E2263D6DDQ39776941-A105248D-3CAA-4BE6-B57B-66AEA5AC299AQ46248987-24312417-4CF8-4F1A-855C-BFE8E0EEE069Q46763977-BE11DD28-ECA6-4565-B520-E97B8ECA092BQ47855039-D924FE94-3DE2-4473-9CB4-51B5ECD3509EQ52774162-896EA955-E099-4CE3-AF05-EFB973986F1FQ53434982-45EEF134-0001-437D-A03E-054B22BD3656Q54963731-A19C6071-62EE-48D8-B750-4AEED9C32A05
P2860
Emerging significance of NLRs in inflammatory bowel disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging significance of NLRs in inflammatory bowel disease.
@ast
Emerging significance of NLRs in inflammatory bowel disease.
@en
type
label
Emerging significance of NLRs in inflammatory bowel disease.
@ast
Emerging significance of NLRs in inflammatory bowel disease.
@en
prefLabel
Emerging significance of NLRs in inflammatory bowel disease.
@ast
Emerging significance of NLRs in inflammatory bowel disease.
@en
P2093
P2860
P50
P1476
Emerging significance of NLRs in inflammatory bowel disease.
@en
P2093
Beckley K Davis
Irving C Allen
Kristin Eden
P2860
P304
P356
10.1097/MIB.0000000000000151
P577
2014-12-01T00:00:00Z